Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
Oncoimmunology|September 28, 2013
High frequency of T cells specific for cryptic epitopes in melanoma patientsRikke Sick Andersen, Sofie Ramskov Andersen, Mads Duus Hjortsø, et al.
Frontiers in Immunology|June 21, 2021
Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor AntigensGitte Holmen Olofsson, Manja Idorn, Ana Micaela Carnaz Simões, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 3, 2015
Design and validation of conditional ligands for HLA-B*08:01, HLA-B*15:01, HLA-B*35:01, and HLA-B*44:05Thomas Mørch Frøsig, Jiawei Yap, Tina Seremet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2014
T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donorsRikke Lyngaa, Natasja Wulff Pedersen, David Schrama, et al.
Cell Stress|October 29, 2019
Inflammation induced PD-L1-specific T cellsShamaila Munir, Mia Thorup Lundsager, Mia Aabroe Jørgensen, et al.
Cancer Research|February 8, 2012
Dissection of T-cell antigen specificity in human melanomaRikke Sick Andersen, Charlotte Albæk Thrue, Niels Junker, et al.
Cancer Immunology, Immunotherapy : CII|July 3, 2007
Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissueDavid Schrama, Heike Voigt, Andreas O Eggert, et al.
Cancer Immunology, Immunotherapy : CII|January 14, 2009
Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patientsValeska Hofmeister-Mueller, Claudia S Vetter-Kauczok, Ramona Ullrich, et al.
Nature Protocols|April 14, 2012
Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimersRikke Sick Andersen, Pia Kvistborg, Thomas Mørch Frøsig, et al.
Vaccine|December 18, 2004
Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivinKerstin Otto, Mads Hald Andersen, Andreas Eggert, et al.
Pageof 16